Retatrutide Phase 3 results look promising, but the drug is not FDA-approved for public use
Yet many continue to incur costs due to re-initiation or ongoing treatment for obesity-related conditions like type 2 diabetes, hypertension, or sleep apnea
[6] Similar to the human studies, studies in animals showcase both the effectiveness and safety of this peptide in reducing body weight, increasing fat oxidation, and increasing lipolysis in obese animals
Supports Appetite & Metabolic Balance Helps support pathways related to satiety and energy regulation
At the same time, obesity can lead to irregular periods or heavier periods
Sermorelin may indirectly support hepatic metabolism by restoring healthy GH/IGF-1 signaling, but it shouldnt be viewed as a targeted treatment for fatty liver disease until it has been formally studied in that specific population. Sermorelin may also improve sleep quality, an issue affecting 40 to 60 percent of women in the menopause years